Enliven Therapeutics, Inc. (ELVN): 4/A filed Feb 20, 2024

Form type

4/A

Filing date

Feb 20, 2024

Accession number

0001415889-24-004493

Filer

Enliven Therapeutics, Inc. (CIK 1672619)